Our data indicate regulation of IGFBP2 to be more dependent on the lipid status of the liver, as shown in the aP2-SREBP-1c mice with systemic insulin resistance and aggravated fatty liver. This evidence concerns the gene IGFBP2 and Hepatic steatosis.